The FDA announced that Auromedics Pharma LLC, of East Windsor, N.J., has recalled one lot of Zyvox (linezolid) for injection due to the presence of white particulate matter identified as mold. The lot was distributed to hospitals between May 15 and Aug. 14, 2017, with an expiration date of August 2018, and the recall was prompted by the discovery of particulate matter in a single bag of the antibacterial. Linezolid is indicated for use in treatment of Gram-positive bacteria, such as nosocomial pneumonias.